Gene · 5252
Papers3,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mucoid Degeneration of Posterior Cruciate Ligament - A Case Study. | J Orthop Case Rep | 2024 | 39524258 | PubTator, text mining | PubMed |
| Surgical Management of Complex Multiligament Knee Injury: Case Report. | Case Rep Orthop | 2024 | 39463917 | PubTator, text mining | PubMed |
| Establishment and Characterization of a Stable Producer Cell Line Generation Platform for the Manufacturing of Clinical-Grade Lentiviral Vectors. | Biomedicines | 2024 | 39457578 | PubTator, text mining | PubMed |
| TFE3-Rearranged Tumors of the Kidney: An Emerging Conundrum. | Cancers (Basel) | 2024 | 39410016 | PubTator, text mining | PubMed |
| Scalable fabrication of porous membrane incorporating human extracellular matrix-like collagen for guided bone regeneration. | J Mater Chem B | 2024 | 39373469 | PubTator, text mining | PubMed |
| Perturbation Training in Anterior Cruciate Ligament Graft Tear and Posterolateral Corner Injury: A Case Report of a Combined Injury. | Cureus | 2024 | 39371700 | PubTator, text mining | PubMed |
| A potential conundrum in dermatopathology: molecularly confirmed superficial ossifying fibromyxoid tumors with unusual histomorphologic findings and a novel fusion. | Virchows Arch | 2024 | 39367284 | PubTator, text mining | PubMed |
| Syk inhibitors reduce tau protein phosphorylation and oligomerization. | Neurobiol Dis | 2024 | 39233131 | PubTator, text mining | PubMed |
| Patient-Reported Experiences of Persistent Post-COVID-19 Conditions After Hospital Discharge During the Second and Third Waves of the Pandemic in Switzerland: Cross-Sectional Questionnaire Study. | JMIR Public Health Surveill | 2024 | 39197160 | PubTator, text mining | PubMed |
| Can cereal-based oral contrast agents-assisted ultrasound become an alternative to non-contrast magnetic resonance imaging (MRI) in radiological follow-up for pancreatic cystic lesions? | Quant Imaging Med Surg | 2024 | 39144011 | PubTator, text mining | PubMed |
| Ossifying Fibromyxoid Tumor of the Shoulder: A Case Report. | Cureus | 2024 | 39070435 | PubTator, text mining | PubMed |
| Psychopathology symptoms of frontline nurses under sudden public health crisis: A network analysis. | Stress Health | 2024 | 39046923 | PubTator, text mining | PubMed |
| Utility of an anchored multiplex polymerase chain reaction-based fusion assay for diagnosis of soft tissue tumors in cytology. | Cancer Cytopathol | 2024 | 38944697 | PubTator, text mining | PubMed |
| Epigenetic modulators provide a path to understanding disease and therapeutic opportunity. | Genes Dev | 2024 | 38914477 | PubTator, text mining | PubMed |
| Progressive Late-Onset Genu Recurvatum Post-Total Knee Arthroplasty: Insights from a Spinal Stenosis-Related Case Series. | Arch Bone Jt Surg | 2024 | 38817415 | PubTator, text mining | PubMed |
| Deciphering the dual roles of PHD finger proteins from oncogenic drivers to tumor suppressors. | Front Cell Dev Biol | 2024 | 38813086 | PubTator, text mining | PubMed |
| Virtual reality-based simulation learning on geriatric oral health care for nursing students: a pilot study. | BMC Oral Health | 2024 | 38807116 | PubTator, text mining | PubMed |
| Similar Recovery Rate for Patients Aged between 50 and 89 Years That Go Home on the Surgery Day and Self-Administer Their Rehabilitation after Kinematically Aligned Total Knee Arthroplasty. | J Pers Med | 2024 | 38793086 | PubTator, text mining | PubMed |
| The influence of APOEε4 on the pTau interactome in sporadic Alzheimer's disease. | Acta Neuropathol | 2024 | 38772917 | PubTator, text mining | PubMed |
| Thread Lifting Materials: A Review of Its Difference in Terms of Technical and Mechanical Perspective. | Clin Cosmet Investig Dermatol | 2024 | 38737945 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5252/papers?page=10